Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 121 - 130 of 1441 shown below

  • Gallotta, V

    G Ferrandina, F Legge, E Martinelli, F O Ranelletti, G F Zannoni, L Lauriola, M Gessi, V Gallotta and G Scambia

    Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters

    advance online publication, 2005-01-18 00:00:00.000;

    doi:10.1038/sj.bjc.6602332

  • Galluccio, N

    F Loupakis, A Ruzzo, C Cremolini, B Vincenzi, L Salvatore, D Santini, G Masi, I Stasi, E Canestrari, E Rulli, I Floriani, K Bencardino, N Galluccio, V Catalano, G Tonini, M Magnani, G Fontanini, F Basolo, A Falcone and F Graziano

    KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    advance online publication, 2009-07-14 00:00:00.000;

    doi:10.1038/sj.bjc.6605177

  • Gallus, S

    C Bosetti, S Gallus, S Franceschi, F Levi, M Bertuzzi, E Negri, R Talamini and C La Vecchia

    Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers

    doi:10.1038/sj.bjc.6600469

  • S Gallus, M Bertuzzi, A Tavani, C Bosetti, E Negri, C La Vecchia, P Lagiou and D Trichopoulos

    Does coffee protect against hepatocellular carcinoma?

    doi:10.1038/sj.bjc.6600582

  • A Altieri, C Bosetti, R Talamini, S Gallus, S Franceschi, F Levi, L Dal Maso, E Negri and C La Vecchia

    Cessation of smoking and drinking and the risk of laryngeal cancer

    doi:10.1038/sj.bjc.6600638

  • A Tavani, M Soler, C La Vecchia, E Negri, S Gallus and S Franceschi

    Body weight and risk of soft-tissue sarcoma

    doi:10.1038/sj.bjc.6690781

  • S Franceschi, S Gallus, R Talamini, A Tavani, E Negri and C La Vecchia

    Menopause and colorectal cancer

    doi:10.1054/bjoc.1999.1084

  • S Gallus, C Bosetti, S Franceschi, F Levi, L Simonato, E Negri and C La Vecchia

    Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors

    doi:10.1054/bjoc.2001.1898

  • Galmarini, C M

    C M Galmarini, K Kamath, A Vanier-Viornery, V Hervieu, E Peiller, N Falette, A Puisieux, M Ann Jordan and C Dumontet

    Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

    doi:10.1038/sj.bjc.6600960

  • M Serova, C M Galmarini, A Ghoul, K Benhadji, S R Green, J Chiao, S Faivre, E Cvitkovic, C Le Tourneau, F Calvo and E Raymond

    Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells

    advance online publication, 2007-07-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603896

  • B P Bouchet, J Bertholon, N Falette, C Audoynaud, C Lamblot, A Puisieux and C M Galmarini

    Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype

    advance online publication, 2007-10-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603936

  • C M Galmarini, N Falette, E Tabone, C Levrat, R Britten, N Voorzanger-Rousselot, O Roesch-Gateau, A Vanier-Viornery, A Puisieux and C Dumontet

    Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity

    doi:10.1054/bjoc.2001.2017

  • Galteland, E

    T Stokke, P DeAngelis, L Smedshammer, E Galteland, H B Steen, E B Smeland, J Delabie and H Holte

    Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

    doi:10.1054/bjoc.2001.2164

  • Galukande, M

    A Gakwaya, J B Kigula-Mugambe, A Kavuma, A Luwaga, J Fualal, J Jombwe, M Galukande and D Kanyike

    Cancer of the breast: 5-year survival in a tertiary hospital in Uganda

    advance online publication, 2008-06-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604435

  • Galustian, C

    S Nizar, J Copier, B Meyer, M Bodman-Smith, C Galustian, D Kumar and A Dalgleish

    T-regulatory cell modulation: the future of cancer immunotherapy?

    advance online publication, 2009-04-21 00:00:00.000;

    doi:10.1038/sj.bjc.6605040

  • W M Liu, J Y Henry, B Meyer, J B Bartlett, A G Dalgleish and C Galustian

    Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605206

  • Galve-Roperh, I

    M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria

    A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

    advance online publication, 2006-06-27 00:00:00.000;

    doi:10.1038/sj.bjc.6603236

  • Galy, O

    A Bengochea, M M de Souza, L Lefrançois, E Le Roux, O Galy, I Chemin, M Kim, J R Wands, C Trepo, P Hainaut, J-Y Scoazec, L Vitvitski and P Merle

    Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma

    advance online publication, 2008-06-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604422

  • Gamallo, C

    J M Garcia, R Gonzalez, J M Silva, G Dominguez, I S Vegazo, C Gamallo, M Provencio, P España and F Bonilla

    Mutational status of K- ras and TP53 genes in primary sarcomas of the heart

    doi:10.1054/bjoc.1999.1060